Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dysbiosis × Metronidazole × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 5 Surgical Wound Infection 4 Rectal Neoplasms 4 Pancreatic Neoplasms 3 Lymphoma 3 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Postoperative Complications 1 Pilonidal Sinus 1 Persistence of Infection With Helicobacter Pylori 1 Mouth Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Familial primary gastric lymphoma 1 Dysbiosis 1 Diverticulitis 1 Colonic Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Observation 1 Metronidazole 1 Lacteol 1 Esomeprazole 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡